Finotonlimab Injection Application Scope

Indication: Recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC), first-line in combination with platinum-based chemotherapy.

Finotonlimab Injection Characteristics

Ingredients: Recombinant humanized anti-PD-1 monoclonal antibody (finotonlimab).
Properties: PD-1 immune checkpoint inhibitor; restores T-cell anti-tumor activity.
Packaging Specification: 100 mg (4 mL) / vial × 1 vial/box.
Storage: Store at 2–8 °C. Do not freeze. Protect from light.
Expiry Date: As printed on package.
Executive Standard: Per registered product quality standard.
Approval Number: As indicated on approval document.
Date of Revision: As shown on label.
Manufacturer: Sinocelltech / Sinocell Technologies Ltd.

Guidelines for the Use of Anyouping

Dosage and Administration:
- Recommended Dose: 200 mg IV every 3 weeks.
- Administration: Intravenous infusion; dilute and infuse as directed.
- Missed Dose: If a dose is missed, administer as soon as possible and resume the 3-week schedule.
Adverse Reactions:
- Common Adverse Reactions: Fatigue, infusion-related reactions, rash, pruritus, decreased appetite, nausea, diarrhea, cough, pyrexia.
- Serious Adverse Reactions: Immune-related adverse events: pneumonitis, hepatitis, colitis, endocrinopathies, adrenal insufficiency, severe infections.
Contraindications:
- Hypersensitivity to finotonlimab or excipients.
- Use in pregnancy only if clearly needed.
Precautions:
- Monitor for immune-related toxicities (liver, thyroid, pulmonary, GI).
- Caution in autoimmune disease or immunosuppressive therapy.
- Avoid live vaccines during treatment.

Finotonlimab Injection Interactions

Immunosuppressants (e.g., high-dose corticosteroids) may reduce efficacy.
No major CYP-mediated drug interactions.
Monitor with drugs that increase infection risk or affect immune function.

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.